INVICTUS: intravitreal anti-VEGF and dexamethasone implant comparison for the treatment of diabetic macular edema: a 6 months follow-up Study

Acta Ophthalmologica

Volumn 97, Issue 6, 2019, Pages e937-e938

  Comet, Alban ^a   Gascon, Pierre ^a,b   Sauvan, Lauren ^a   Donnadieu, Benjamin ^a   Matonti, Frédéric ^a,b,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c Centre Monticelli Paradis   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; DEXAMETHASONE; RANIBIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; FUSION PROTEIN; GLUCOCORTICOID; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

AGED; BEST CORRECTED VISUAL ACUITY; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE FUNDUS; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LETTER; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; COMBINATION DRUG THERAPY; COMPLICATION; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG IMPLANT; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; TIME FACTOR; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; DEXAMETHASONE; DIABETIC RETINOPATHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; RANIBIZUMAB; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 85061346418     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.14057     Document Type: Letter

References (5)

1. Boyer DS, Yoon YH, Belfort RJ et al. (2014): Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121: 1904–1914.
2. Callanan DG, Loewenstein A, Patel SS et al. (2017): A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 255: 463–473.
3. Do DV, Schmidt-Erfurth U, Gonzalez VH et al. (2011): The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Ophthalmology 118: 1819–1826.
4. Gillies MC, Lim LL, Campain A et al. (2014): A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology 121: 2573–2581.
5. Souied EH, Gekkiev B, Bretagne A et al. (2015): Ranibizumab in a real-world clinical setting: 2014 interim analysis of the 5-year observational multicenter LUMINOUS study. Invest Ophthalmol Vis Sci 56: 1417.